Amgen’s Surfaceome Platform advances the discovery and validation of cell type-specific surface targets across disease areas to enable targeted therapeutics. The Surface Biology early validation group triages proteomics- and transcriptomics-derived hits, defines actionable target properties, and guides early therapeutic modality selection. The Senior Scientist will conduct quantitative characterization of surface targets and use knowledge of modality-specific mechanisms and requirements to propose and experimentally evaluate therapeutic modalities. The role helps guide target prioritization and early therapeutic strategy by developing scalable workflows, assessing target and cellular responses, and integrating findings into Go/No-Go decisions. The scientist will collaborate across teams, document workflows, and present validated data in cross-functional discussions.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree